Tag: Rocatinlimab

Markets

Amgen Reports Preliminary Phase 3 Trial Results For Rocatinlimab In Moderate-to-Severe AD

09/09/2025
mhsj

(RTTNews) – Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced preliminary top-line results from the ASCEND…